These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4298252)

  • 1. Influence of mammary tumor virus on the tumor-producing capabilities of nodule outgrowth free of mammary tumor virus.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1968 Jun; 40(6):1303-8. PubMed ID: 4298252
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1969 Feb; 42(2):303-10. PubMed ID: 4303882
    [No Abstract]   [Full Text] [Related]  

  • 3. Serial transplantation of urethan-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1371-5. PubMed ID: 4337908
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and characterization of the BALB/cNIV mouse strain.
    Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
    Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract]   [Full Text] [Related]  

  • 6. Transformation of rat mammary cell cultures by R-35 virus isolated from spontaneous rat mammary adenocarcinoma.
    Ahmed M; Korol W; Larson D; Molnar H; Schidlovsky G
    J Natl Cancer Inst; 1972 Apr; 48(4):1077-83. PubMed ID: 4336870
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic aspects of tumor induction by mammary tumor virus.
    Blair PB
    J Natl Cancer Inst; 1972 Apr; 48(4):1121-4. PubMed ID: 4336876
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammary gland as a morphological end point in carcinogenesis studies.
    Medina D
    J Toxicol Environ Health; 1976 Mar; 1(4):551-60. PubMed ID: 177787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron microscopy of cell transformation by R-35 rat virus and comparative morphology with other oncogenic viruses.
    Schidlovsky G; Ahmed M; Slattery S; Lowry G
    J Natl Cancer Inst; 1972 Apr; 48(4):1067-75. PubMed ID: 4112453
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus.
    Faulkin LJ; Mitchell DJ; Young LJ; Morris DW; Malone RW; Cardiff RD; Gardner MB
    J Natl Cancer Inst; 1984 Oct; 73(4):971-82. PubMed ID: 6090752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-tumor-incidence subline of the D1 mouse mammary hyperplastic outgrowth line: effect of carcinogens.
    Ashley RL; Cardiff RD; Pratt TS; Faulkin LJ
    J Natl Cancer Inst; 1982 Sep; 69(3):639-45. PubMed ID: 6287083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse models of mammary tumorigenesis.
    Cardiff RD; Muller WJ
    Cancer Surv; 1993; 16():97-113. PubMed ID: 8394206
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
    Morton DL
    J Natl Cancer Inst; 1969 Feb; 42(2):311-20. PubMed ID: 4303883
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of dietary phenylalanine deficiency on the mammary tumor virus activity in C3H mice.
    Hui YH; DeOme KB; Briggs GM
    Cancer Res; 1972 Oct; 32(10):2086-8. PubMed ID: 4343007
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined effects of 3-methylcholanthrene, mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation on the tumor-producing capabilities of the nodule outgrowth line D1.
    Medina D; Faulkin LJ; DeOme KB
    J Natl Cancer Inst; 1970 Jan; 44(1):159-65. PubMed ID: 11515027
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of resistance to mammary tumor development in C57BL and I strains of mice. I. Noduligenesis, tumorigenesis, and characteristics of nodules and tumors.
    Nandi S; Haslam S; Helmich C
    J Natl Cancer Inst; 1972 Apr; 48(4):1005-12. PubMed ID: 4336864
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonspecific life shortening in male mice exposed to the mammary tumor agent.
    Storer JB
    J Natl Cancer Inst; 1966 Aug; 37(2):211-5. PubMed ID: 4287953
    [No Abstract]   [Full Text] [Related]  

  • 18. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
    Vaage J; Medina D
    Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse mammary tumor virus infectivity as a function of age at inoculation, breeding, and total lapsed time.
    Moore DH; Charney J; Pullinger BD
    J Natl Cancer Inst; 1970 Sep; 45(3):561-5. PubMed ID: 4331643
    [No Abstract]   [Full Text] [Related]  

  • 20. Mammary tumor virus potentiation of endogenous prolactin effect on mammary gland differentiation.
    Ben-David M; Heston WE; Rodbard D
    J Natl Cancer Inst; 1969 Feb; 42(2):207-18. PubMed ID: 4303880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.